Business
“Reality check”: In early data, AstraZeneca vaccine offers minimal protection against South African variant – Sydney Morning Herald
Australian health authorities have backed AstraZeneca’s vaccine despite South Africa’s decision to pause roll-out of the jab, after early clinical data showed it…

It remains unclear if the vaccine will still protect against serious illness and death; scientists who were part of the South African trial are hopeful it will.
The University of Oxford, which co-developed the vaccine, said it was working on a booster jab to provide protection against the variant, if necessary.
CSL, which is contracted by the government and AstraZeneca to produce 50 million doses of the vaccine at its Broadmeadows plant, did not comment directly on whether it could modify the jab…
-
General19 hours ago
Cohealth’s closure of three Melbourne GP clinics to affect 12,500 patients
-
General21 hours ago
Financial Hardship A Top Telco Complaint For Fed Up Aussies
-
General21 hours ago
WA inquiry into firearms law admits issues with digital portal and communication on implementation
-
Noosa News21 hours ago
Queensland government approves Arrow Energy gas plant